By Ed Lamb, DrugPatentWatch writer Under a new commissioner dedicated to bolstering competition to reduce prices, the agency is redoing a raft of rules and guidances to speed ANDA approvals…
The post FDA Pushes to Reduce Single-Source Generics, I…
FDA Pushes to Reduce Single-Source Generics, Increase Biosimilars Read Post »
For pharmaceutical companies in flux, contract services are playing a pivotal and more diverse role in the drug development process. The rapid growth of the contract research organization or CRO…
The post When should you outsource drug developmen…
Annual Drug Patent Expirations for BOSULIF Bosulif is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are five…
The post New patent expiration for Pf Prism drug BOSULIF appeared first on DrugPa…
The FDA was established to ensure the safety of food and medicines sold in the US. Sadly, the original charter is now slowly being affected by the advocates of drug…
The post Is importing drugs a risky affair? appeared first on DrugPatentWatch.
Annual Drug Patent Expirations for TOPICORT Topicort is a drug marketed by Taro and is included in ten NDAs. It is available from three suppliers. There are three patents protecting…
The post New patent expiration for TARO drug TOPICORT appeared …
Annual Drug Patent Expirations for CLOBEX Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from five suppliers.…
The post New patent expiration for Galderma Labs drug CLOBEX appeared f…
New patent expiration for Galderma Labs drug CLOBEX Read Post »
Annual Drug Patent Expirations for ALTOPREV Altoprev is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Covis Pharma drug ALTOPREV appeared first o…
New patent expiration for Covis Pharma drug ALTOPREV Read Post »
This article was originally published by Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang in Globalization and Health201713:21 under a Creative Commons License. Abstract…
The post Obstacles and opportunities in Chin…
Obstacles and opportunities in Chinese pharmaceutical innovation Read Post »
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Schering drug REBETOL appeared first…
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug REBETOL appeared fi…
New patent expiration for Merck Sharp drug REBETOL Read Post »
Get new actionable insights and updates from BiotechBlog
